UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 121

Sortiert nach

Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies

Cancers, 2023-04, Vol.15 (9), p.2532

2023

Volltextzugriff (PDF)

Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways

Haematologica (Roma), 2022-01, Vol.107 (1), p.187

2022

Volltextzugriff (PDF)

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

Cancers, 2019-11, Vol.11 (12), p.1833

2019

Volltextzugriff (PDF)

The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL

Cancers, 2023-04, Vol.15 (9), p.2527

2023

Volltextzugriff (PDF)

Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma

Cancers, 2021-11, Vol.13 (22), p.5867

2021

Volltextzugriff (PDF)

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle

The Journal of pathology, 2013-08, Vol.230 (4), p.399-409

2013

Volltextzugriff (PDF)

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

Biomarker research, 2020-10, Vol.8 (1), p.54-54, Article 54

2020

Volltextzugriff (PDF)

AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1

Current cancer drug targets, 2014-10, Vol.14 (8), p.700

2014

Volltextzugriff (PDF)

The dawn of a new era in treating T-PLL

Oncotarget, 2019-01, Vol.10 (6), p.626-628

2019

Volltextzugriff (PDF)

Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas

Cell communication and signaling, 2012-12, Vol.10 (1), p.43-43

2012

Volltextzugriff (PDF)

Interleukin-2-inducible T-cell Kinase (ITK) Targeting by BMS-509744 Does Not Affect Cell Viability in T-cell Prolymphocytic Leukemia (T-PLL)

The Journal of biological chemistry, 2015-04, Vol.290 (16), p.10568-10569

2015

Volltextzugriff (PDF)

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Blood, 2014-08, Vol.124 (9), p.1460-1472

2014

Volltextzugriff (PDF)

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

Cancer research (Chicago, Ill.), 2022-05, Vol.82 (9), p.1818-1831

2022

Volltextzugriff (PDF)

Next‐generation amplicon TRB locus sequencing can overcome limitations of flow‐cytometric Vβ expression analysis and confirms clonality in all T‐cell prolymphocytic leukemia cases

Cytometry. Part A, 2018-11, Vol.93 (11), p.1118-1124

2018

Volltextzugriff (PDF)

T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

Genes chromosomes & cancer, 2022-07, Vol.61 (7), p.432-436

2022

Volltextzugriff (PDF)

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas

Blood, 2011-06, Vol.117 (22), p.5907-5917

2011

Volltextzugriff (PDF)

Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC‐subtype diffuse large B‐cell lymphoma

The Journal of pathology, 2019-06, Vol.248 (2), p.142-154

2019

Volltextzugriff (PDF)

Abstract 1372: Towards novel strategies of targeting specific vulnerabilities of T-PLL cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1372-1372

2017

Volltextzugriff (PDF)

New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance

Leukemia & lymphoma, 2019-02, Vol.60 (3), p.649-657

2019

Volltextzugriff (PDF)

Genomic data integration using guided clustering

Bioinformatics, 2011-08, Vol.27 (16), p.2231-2238

2011

Volltextzugriff (PDF)

CD1d-restricted peripheral T cell lymphoma in mice and humans

The Journal of experimental medicine, 2016-05, Vol.213 (5), p.841-857

2016

Volltextzugriff (PDF)

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

Molecular cancer, 2015-06, Vol.14 (1), p.114-114, Article 114

2015

Volltextzugriff (PDF)

OS-092 Targeting cellular cathepsins inhibits hepatitis E virus infection

Journal of hepatology, 2024-06, Vol.80, p.S58-S59

2024

Volltextzugriff (PDF)

Novel Mutations in NOTCH and Altered Wnt/β-Catenin Pathway Indicate a Role of Embryonic Signals in the Pathogenesis of T-Cell Prolymphocytic Leukemia

Blood, 2016-12, Vol.128 (22), p.4103-4103

2016

Volltextzugriff (PDF)

1 – 25 von 121

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(111)

Publikationsform

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Education and Empowering Special Forces to Eradicate Secret Defectors: Immune System-Based Treatment Approaches for Mature T- and NK-Cell Malignancies

Micro-RNA networks in T-cell prolymphocytic leukemia reflect T-cell activation and shape DNA damage response and survival pathways

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

The miR-141/200c-STAT4 Axis Contributes to Leukemogenesis by Enhancing Cell Proliferation in T-PLL

Beyond the Usual Suspects: Hepatitis E Virus and Its Implications in Hepatocellular Carcinoma

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia

AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1

The dawn of a new era in treating T-PLL

Global gene expression changes of in vitro stimulated human transformed germinal centre B cells as surrogate for oncogenic pathway activation in individual aggressive B cell lymphomas

Interleukin-2-inducible T-cell Kinase (ITK) Targeting by BMS-509744 Does Not Affect Cell Viability in T-cell Prolymphocytic Leukemia (T-PLL)

Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia

Noncanonical Function of AGO2 Augments T-cell Receptor Signaling in T-cell Prolymphocytic Leukemia

Next‐generation amplicon TRB locus sequencing can overcome limitations of flow‐cytometric Vβ expression analysis and confirms clonality in all T‐cell prolymphocytic leukemia cases

T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas

Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia

Regulation of S1PR2 by the EBV oncogene LMP1 in aggressive ABC‐subtype diffuse large B‐cell lymphoma

Abstract 1372: Towards novel strategies of targeting specific vulnerabilities of T-PLL cells

New lessons learned in T-PLL: results from a prospective phase-II trial with fludarabine-mitoxantrone-cyclophosphamide-alemtuzumab induction followed by alemtuzumab maintenance

Genomic data integration using guided clustering

CD1d-restricted peripheral T cell lymphoma in mice and humans

Organometallic nucleosides induce non-classical leukemic cell death that is mitochondrial-ROS dependent and facilitated by TCL1-oncogene burden

OS-092 Targeting cellular cathepsins inhibits hepatitis E virus infection

Novel Mutations in NOTCH and Altered Wnt/β-Catenin Pathway Indicate a Role of Embryonic Signals in the Pathogenesis of T-Cell Prolymphocytic Leukemia

Suchergebnisse filtern